Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PA3552-IN-1

Copy Product Info
😃Good
Catalog No. T67912Cas No. 1008121-12-7

PA3552-IN-1 is an antibiotic adjuvant that can reduce the expression of PA3552 and restore the sensitivity of MDR Pseudomonas aeruginosa DK2 strain to Polymyxin B.

PA3552-IN-1

PA3552-IN-1

Copy Product Info
😃Good
Purity: 99.82%
Catalog No. T67912Cas No. 1008121-12-7
PA3552-IN-1 is an antibiotic adjuvant that can reduce the expression of PA3552 and restore the sensitivity of MDR Pseudomonas aeruginosa DK2 strain to Polymyxin B.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$41-In Stock
25 mg$83-In Stock
50 mg$138-In Stock
100 mg$209-In Stock
200 mg$295-In Stock
1 mL x 10 mM (in DMSO)$29-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.82%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

PA3552-IN-1 AI Summary
PA3552-IN-1 exhibits notable cytotoxic effects against human cancer cell lines HL60, KG1, Jurkat, and NALM6, with IC50 values of 280.0 nM, 490.0 nM, 530.0 nM, and 910.0 nM respectively. It also inhibits the binding between KIX-RLucN fused CBP and KID-RLucC fused CREB in human HEK293 cells with an IC50 of 1520.0 nM. Additionally, PA3552-IN-1 shows bioactivity against the Zika virus by inhibiting NS-1 and envelope protein with IC50 values of 1720.0 nM and 1340.0 nM, respectively. With a solubility of 3.3 µg/mL, the compound also demonstrates cytotoxicity against African Green monkey Vero E6 cells with a CC50 of 8150.0 nM and exhibits good permeability in a PAMPA assay with a permeability value of 30.7 x 10^-6 cm/s. Moreover, PA3552-IN-1 shows antimicrobial activity against strains such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. It presents synergistic antibacterial effects when combined with polymyxin B and significantly reduces bacterial growth, enhancing survival rates in Caenorhabditis elegans infected with Pseudomonas aeruginosa. The compound also suppresses drug resistance development in Pseudomonas aeruginosa but exhibits acute toxicity in ICR mice at high doses..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PA3552-IN-1 is an antibiotic adjuvant that can reduce the expression of PA3552 and restore the sensitivity of MDR Pseudomonas aeruginosa DK2 strain to Polymyxin B.
Chemical Properties
Molecular Weight310.67
FormulaC13H8ClFN2O4
Cas No.1008121-12-7
SmilesOc1ccc(F)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O
Relative Density.1.595 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 12.5 mg/mL (40.24 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2188 mL16.0942 mL32.1885 mL160.9425 mL
5 mM0.6438 mL3.2188 mL6.4377 mL32.1885 mL
10 mM0.3219 mL1.6094 mL3.2188 mL16.0942 mL
20 mM0.1609 mL0.8047 mL1.6094 mL8.0471 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PA3552-IN-1 | purchase PA3552-IN-1 | PA3552-IN-1 cost | order PA3552-IN-1 | PA3552-IN-1 chemical structure | PA3552-IN-1 formula | PA3552-IN-1 molecular weight